PLx Pharma Inc. Raises $8 Million, Filings Show  
3/21/2013 9:19:00 AM

Houston-based PLx Pharma Inc. raised about $8.3 million, according to regulatory filings. Ronald Zimmerman, president and CEO of PLx, declined to comment on the raise. "We don't make any comments about our fundraising," Zimmerman said. PLx focuses development efforts on drug products with active ingredients that have already been approved for marketing by the U.S. Food and Drug Administration, according to the company's website. Last year, the pharmaceutical company received a $565,449 grant to conduct research for a medication for premature babies with a congenital heart defect. The grant may be extended to two years, bringing the total to $1.1 million.